CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use this state record to trace the legal requirement, then compare it with the terms an office adds. The full work explains the constitutional case, consent analysis, evidence needed, and protections to demand.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
New Mexico · Government baseline and facility evidence
What did the state require, and what did the office add?
NM-R identifies licensing rules within their prescriber-specific scope; NM-I identifies conditional payer obligations; NM-G identifies guidance rather than compulsory private wording. NM-X means the exact condition was not established as mandatory by the reviewed government sources. An office addition is not automatically unlawful. A requirement for a treatment agreement does not make every private clause a state requirement.
NM-R · Prescriber-specific rules
The Medical Board rule, 16.10.14 NMAC covers its licensed practitioners. Section .9 requires written agreements for chronic-pain controlled analgesics, a single practitioner and pharmacy when possible, treatment review at least every six months, and baseline plus six-month urine testing for chronic opioid therapy. Legitimate pain care is not categorically precluded by addiction, dependence or tolerance; closer monitoring is required. Chronic-pain definitions exclude specified terminal/progressive conditions. Section .8 requires PMP review initially for covered prescriptions longer than four days or following a 30-day prescribing gap, then at least quarterly during continuous prescribing, with listed exceptions. A dose above 90 MME triggers risk review, not an automatic ceiling. Section .13 requires antagonist co-prescribing with an opioid supply of at least five days. Apply the complete rule and its exceptions.
The osteopathic rule, 16.17.4.8 separately requires agreements and qualified single-practitioner/pharmacy coordination for chronic non-cancer controlled-analgesic treatment. It also recognizes legitimate pain treatment in people with addiction, dependence or tolerance. Do not assume one professional board’s language applies to every prescriber.
The Board of Nursing rule, 16.12.9, effective May 21, 2024 covers advanced practice nurses with prescriptive authority. Section .8(C)(6) requires a written agreement for chronic non-cancer controlled-analgesic treatment and one practitioner/pharmacy whenever possible. Its treatment-review minimum is every three months, not the Medical Board’s six months. Section .8(B) addresses drug screens before and during opiate treatment; .8(C)(7) addresses elevated-risk screening. Check the actual prescriber and circumstances before assigning a baseline.
NM-G · Guidance is not a private contract mandate
State publication of a sample or discussion of agreements does not make every private clause compulsory. This supplement does not treat historical implementation reports as current clinic agreements. Current professional rules, document versions, adoption and enforcement must be assessed separately.
NM-I · Insurance, laboratory choice and costs
Network participation, covered services and patient cost-sharing depend on the plan and service. A private financial form does not settle what is legally owed. Ask for the laboratory, procedure, expected cost, alternatives and consequence of declining. Disclosure of ownership does not itself establish an exclusive purchase requirement.
NM-X · Exact mandate not established
The reviewed pain-prescribing baseline does not establish the exact private payment, belongings-search, liability-release, replacement or cancellation conditions selected here. This is a research classification, not a determination that a clause is unlawful. The need for individualized treatment or monitoring does not by itself establish a requirement to buy a particular business’s service.
Source register and version boundaries
- NM Pain Associates service agreement and general consent: April 2023 filenames; address differs from the current forms page. Confirm current adoption.
- Alamogordo-hosted 2021 packet: unresolved template fields; current use unverified. Do not transfer it to other branches.
- Agape patient webpage: refill policy, not a recovered complete opioid agreement.
- New Mexico Pain Center locations, New Mexico Center for Pain & Wellness, UNM pain service and San Juan Regional Interventional Spine: location evidence with agreement gaps. The two similarly named private networks are distinct.
The existing evidence library, Presbyterian historical implementation record and Northern Navajo historical record remain available. Those records are not recast as current 2026 facility contracts; federal or tribal settings also require jurisdiction-specific analysis.
Reviewed October 14, 2026. Public documents establish published wording, not current branch adoption, enforcement, appointment availability or a promise of medication. No practice was contacted. Inclusion is not an endorsement or legal finding.